Exploring clinical perspectives in advanced EGFR-mutant NSCLC: How far we have come

Learning objective:         

After watching this broadcast, participants should be able to:

• Reflect on perspectives in the management of EGFR-mutant NSCLC
• Evaluate the latest evidence in EGFR exon 20 insertion mutations and explore how these might impact clinical practice

Faculty:

• Alfredo Addeo (Switzerland)
• Enriqueta Felip (Spain)
• Nicolas Girard (France)
• Zosia Piotrowska (US)
  
  
  

Claim your CPD credits

The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.

You can claim 1.5 credits for this activity.

Please make a note of the below information to claim your points.

Name of activity: Exploring clinical perspectives in advanced EGFR-mutant NSCLC: How far we have come, 30 March 2023, Copenhagen.

Certificate number: 41642

Date of activity: May 2023

CPD Provider: Sciterion 013096